Locus Cell Co., Ltd. (TPEX:6891)
Taiwan
· Delayed Price · Currency is TWD 88.30
+8.90 (11.21%)
Apr 29, 2026, 10:40 AM CST
Locus Cell Market Cap
Locus Cell has a market cap or net worth of 15.88 billion as of April 28, 2026. Its market cap has increased by 258.55% in one year.
Market Cap
15.88B
Enterprise Value
15.43B
Revenue
12.74M
Ranking
n/a
PE Ratio
n/a
Stock Price
88.30
Market Cap Chart
Since April 28, 2022, Locus Cell's market cap has increased from 9.88B to 15.88B, an increase of 60.77%. That is a compound annual growth rate of 12.59%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Apr 28, 2026 | 15.88B | 176.17% |
| Dec 31, 2025 | 5.75B | 44.14% |
| Dec 31, 2024 | 3.99B | -36.67% |
| Dec 29, 2023 | 6.30B | -12.86% |
| Dec 30, 2022 | 7.23B | -26.82% |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| TaiMed Biologics | 13.20B |
| EirGenix | 13.95B |
| Polaris Group | 15.05B |
| Ever Supreme Bio Technology | 11.43B |
| CHO Pharma | 11.39B |
| Medigen Vaccine Biologics | 15.94B |
| Tanvex BioPharma | 10.62B |
| AP Biosciences | 16.30B |